Meta-analysis comparing direct oral anticoagulants versus warfarin in morbidly obese patients with atrial fibrillation
K Kido, M Shimizu, T Shiga, M Hashiguchi - The American journal of …, 2020 - Elsevier
Highlights•Direct oral anticoagulants did not increase stroke or systemic embolism event
rate.•Direct oral anticoagulants had lower major bleeding rate than warfarin.•Direct oral …
rate.•Direct oral anticoagulants had lower major bleeding rate than warfarin.•Direct oral …
Meta-Analysis Comparing Direct Oral Anticoagulants Versus Warfarin in Morbidly Obese Patients With Atrial Fibrillation
K Kido, M Shimizu, T Shiga… - American Journal of …, 2020 - keio.elsevierpure.com
抄録 The International Society of Thrombosis and Haemostasis recommends warfarin
therapy over direct oral anticoagulants (DOACs) in patients with a body mass index> 40 …
therapy over direct oral anticoagulants (DOACs) in patients with a body mass index> 40 …
Meta-Analysis Comparing Direct Oral Anticoagulants Versus Warfarin in Morbidly Obese Patients With Atrial Fibrillation
K Kido, M Shimizu, T Shiga… - The American journal …, 2020 - pubmed.ncbi.nlm.nih.gov
The International Society of Thrombosis and Haemostasis recommends warfarin therapy
over direct oral anticoagulants (DOACs) in patients with a body mass index> 40 kg/m 2 or …
over direct oral anticoagulants (DOACs) in patients with a body mass index> 40 kg/m 2 or …
Meta-Analysis Comparing Direct Oral Anticoagulants Versus Warfarin in Morbidly Obese Patients With Atrial Fibrillation.
K Kido, M Shimizu, T Shiga… - The American Journal of …, 2020 - europepmc.org
The International Society of Thrombosis and Haemostasis recommends warfarin therapy
over direct oral anticoagulants (DOACs) in patients with a body mass index> 40 kg/m2 or …
over direct oral anticoagulants (DOACs) in patients with a body mass index> 40 kg/m2 or …
Meta-Analysis Comparing Direct Oral Anticoagulants Versus Warfarin in Morbidly Obese Patients With Atrial Fibrillation
K Kido, M Shimizu, T Shiga… - American Journal of …, 2020 - ajconline.org
The International Society of Thrombosis and Haemostasis recommends warfarin therapy
over direct oral anticoagulants (DOACs) in patients with a body mass index> 40 kg/m 2 or …
over direct oral anticoagulants (DOACs) in patients with a body mass index> 40 kg/m 2 or …
[引用][C] Meta-Analysis Comparing Direct Oral Anticoagulants Versus Warfarin in Morbidly Obese Patients With Atrial Fibrillation
K Kido, M Shimizu, T Shiga, M Hashiguchi - The American Journal of …, 2020 - cir.nii.ac.jp
Meta-Analysis Comparing Direct Oral Anticoagulants Versus Warfarin in Morbidly Obese
Patients With Atrial Fibrillation | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
Patients With Atrial Fibrillation | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
Meta-Analysis Comparing Direct Oral Anticoagulants Versus Warfarin in Morbidly Obese Patients With Atrial Fibrillation
K Kido, M Shimizu, T Shiga… - American Journal of …, 2020 - keio.elsevierpure.com
Abstract The International Society of Thrombosis and Haemostasis recommends warfarin
therapy over direct oral anticoagulants (DOACs) in patients with a body mass index> 40 …
therapy over direct oral anticoagulants (DOACs) in patients with a body mass index> 40 …